LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders (Q34373636)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders |
scientific article |
Statements
1 reference
LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders (English)
1 reference
Steven D Kahl
1 reference
Linda M Rorick-Kehn
1 reference
Jeffrey M Witkin
1 reference
Michael A Statnick
1 reference
Elizabeth L Eberle
1 reference
Jamie H McKinzie
1 reference
Beth M Forster
1 reference
Conrad J Wong
1 reference
Xia Li
1 reference
Robert S Crile
1 reference
David B Shaw
1 reference
Allison E Sahr
1 reference
Benjamin L Adams
1 reference
Steven J Quimby
1 reference
Nuria Diaz
1 reference
Alma Jimenez
1 reference
Concepcion Pedregal
1 reference
Charles H Mitch
1 reference
Kelly L Knopp
1 reference
Wesley H Anderson
1 reference
Jeffrey W Cramer
1 reference
David L McKinzie
1 reference
23 September 2013
1 reference
1 reference
77
1 reference
131-144
1 reference
Identifiers
1 reference
1 reference